Information for Health Professionals
ASCIA develops Clinical Updates, Action/Treatment Plans, Guides, Checklists, Position Papers/Statements, Guidelines and e-training courses for health professionals.
Quick links for this page
COVID-19
- Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals New March 2021
- Allergy and COVID-19 Vaccination - Guide for health professionals New March 2021
- Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Guide for health professionals New March 2021
Allergen Immunotherapy
- ASCIA Guide - Venom Immunotherapy, References and Consent Form New February 2020
- ASCIA Guide - Aeroallergen Immunotherapy, References, Allergen Selection Guide and Consent Form
- ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated August 2020
- ASCIA Allergen Immunotherapy e-training for health professionals
- ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
Allergic Rhinitis
- ASCIA Clinical Update - Allergic Rhinitis
- ASCIA Treatment Plan - Allergic Rhinitis
- ASCIA Allergic Rhinitis e-training for health professionals
- ASCIA Allergic Rhinitis e-training for pharmacists
- References - Allergic Rhinitis Currently being updated
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
Allergy Prevention and Infant Feeding
- Overview - Infant feeding and allergy prevention
- ASCIA Position Statement - Infant Feeding Products Containing Multiple Common Food Allergens New April 2021
- ASCIA Clinical Update Infant Feeding and Allergy Prevention
- ASCIA Guidelines - Infant feeding and allergy prevention
- ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management
- ASCIA Information on how to introduce solid foods to babies for allergy prevention
- ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy
- References - Allergy Prevention
Anaphylaxis
- ASCIA Guidelines - Acute management of anaphylaxis Updated July 2020
- ASCIA Guidelines - Acute management of anaphylaxis in pregnancy New April 2020
- ASCIA Guidelines - Adrenaline (epinephrine) autoinjector prescription Updated 2020
- ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update
- ASCIA Anaphylaxis Resources Overview
- ASCIA Checklists - Anaphylaxis New and updated 2020
- ASCIA Event record for allergic reactions Updated 2020
- ASCIA Checklist - Transitioning patients from paediatric to adult services Updated 2020
- ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis Updated 2020
- ASCIA Anaphylaxis e-training for health professionals Updated 2020
- ASCIA Anaphylaxis e-training for pharmacists Updated 2020
- References - Anaphylaxis Currently being updated
Drug (Medication) Allergy
- Drug (Medication) Allergy Hub
- ASCIA Action Plan for Drug (Medication) Allergy New August 2020
- ASCIA Record for Drug (Medication) Allergy New August 2020
- ASCIA Drug (Medication) Allergy Terms New August 2020
- ASCIA Penicillin Allergy Guide for health professionals Updated August 2020
- ASCIA Consensus Statement - Penicillin Allergy (available to Members only) Updated August 2020
- ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) Comimg soon
- ASCIA Drug allergy pre-clinic information template (available to Members only)
- ASCIA Clinical Update - Antibiotic Allergy
- ASCIA Penicillin Allergy etraining for health professionals https://etraininghp.ascia.org.au/penicillin-allergy
- References - Drug (Medication) Allergy Currently being updated
Food Allergy
- ASCIA Position Paper - Oral Immunotherapy for Food Allergy New April 2021
- ASCIA Guide - Milk Substitutes in Cow’s Milk Allergy New June 2020
- ASCIA Dietary avoidance information sheets
- ASCIA Information HP - Lupin Allergy
- ASCIA Food Allergy e-training for health professionals
- ASCIA Food Allergy e-training for pharmacists
- ASCIA Food Allergen Challenge Protocols (available to Members only)
- References - Food Allergy Currently being updated
Immunodeficiency
- Immunodeficiency Overview
- ASCIA Immunodeficiency Strategy for Australia and New Zealand Updated October 2020
- References - Immunodeficiency Updated October 2020
- References - Hereditary Angioedema (HAE) Updated October 2020
- ASCIA Webinar - HAE
- ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE)
- ASCIA Clinical Update - Primary Immunodeficiencies (PID)
- ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg)
- ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
- ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
- ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
- ASCIA SCIg Treatment Plan
- ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
- ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
- ASCIA ID Register How to access information (available to Members Only)
Immunisation
- ASCIA Guidelines - vaccination of the egg allergic individual
- ASCIA COVID-19 vaccine information New March 2021
Insect Allergy
- ASCIA Guide - Venom Immunotherapy, References and Consent Form New February 2020
- ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
- ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
- ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
- ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated August 2020
- Information about Venom Immunotherapy availability
Latex Allergy
Skin
- ASCIA Action Plan for Eczema
- ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management
- ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
- ASCIA Position Paper and Guidelines: Chronic Spontaneous Urticaria (CSU)
- References - Chronic Spontaneous Urticaria (CSU) Currently being updated
Tests
- Laboratory Investigation of Allergic Diseases New December 2020
- ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
- References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
- ASCIA Skin Prick Testing (SPT) Guide for Health Professionals New February 2020
- ASCIA Food Allergen Challenge Protocols (available to Members only)
- ASCIA Guidelines - Anti-Intrinsic Factor Antibody Testing
- ASCIA Guidelines - Uncertainty of Measurement
External Documents
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
- Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
- Australian Prescriber Anaphylaxis Wall Chart
- Australian Academy of Science - The science of immunisation
- APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency
- Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
- European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool
For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information
Content updated April 2021